This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
TLR4 Antibody, clone 13E1.1
catalog :
MABF85
quantity :
100 μg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
13E1.1
reactivity :
human
application :
flow cytometry
product information
Catalog Number :
MABF85
Subcategory :
Cell Structure
Product Name :
Anti-TLR4 Antibody, clone 13E1.1
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
O00206
Host Name :
Mouse
Antigen :
TLR4
Clone :
13E1.1
Conjugate :
Purified
Isotype :
IgMκ
Product Description :
Anti-TLR4 Antibody, clone 13E1.1
Cross Reactivity :
Human
Background :
TLR4 is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity.
ALT Names :
Toll-like receptor 4;hToll;CD284
Immunogen :
Linear peptide corresponding to the extracellular domain of human TLR4.
Specificity :
This antibody recognizes the extracellular domain of TLR4.
Package Size :
100 μg
Uses :
Flow Cytometry
Storage :
Stable for 1 year at 2-8°C from date of receipt
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments
